EU Extends Authorization for Levilactobacillus brevis DSM 23231 as Animal Feed Additive

The European Commission has provided strong support for the long-term use of the Levilactobacillus brevis DSM 23231 strain as an animal feed additive. In the Regulation (EU) 2024/1750 officially published on June 25, 2024, the European Commission has explicitly extended the authorization for the use of the Levilactobacillus brevis DSM 23231 preparation (Levilactobacillus brevis DSM 23231) as a feed additive in all animal feed, further consolidating the important status of this additive in the European feed industry.

According to the regulation, the Levilactobacillus brevis DSM 23231 preparation will continue to be authorized for use in the EU as a "silage additive" category under the "technological additives" group. The new authorization period will last until July 15, 2034, providing the industry with a stable outlook for the next decade, which will have a far-reaching impact on promoting long-term planning and innovation in the feed additive industry.

Historically, the EU had already approved the use of this feed additive in August 2019. This decision was based on the excellent performance and significant benefits of the Levilactobacillus brevis DSM 23231 preparation in the field of animal husbandry. Numerous studies have shown that the Levilactobacillus brevis DSM 23231 preparation can effectively improve the quality and preservation of silage, enhance the nutritional value of feed, and thereby promote the healthy growth and efficient production of animals. This advantage is reflected not only in the benefits of animal husbandry, but also in meeting the demands of European consumers for high-quality meat, dairy, and other products.

The decision to extend the authorization period fully reflects the EU's recognition and support for the Levilactobacillus brevis DSM 23231 preparation. This not only provides the relevant industries with a longer-term development space, but also injects new momentum into the innovation and development of the feed additive industry. Industry enterprises can continue to utilize this well-received feed additive, further improve animal husbandry performance and product quality through optimized feeding management and increased feed utilization.

Looking to the future, as consumer attention to food safety and nutritional value continues to increase, the feed additive industry will face more opportunities and challenges. As a safe and efficient feed additive, the Levilactobacillus brevis DSM 23231 preparation will play an increasingly important role in promoting the healthy growth of animals, improving product quality, and meeting consumer demand. At the same time, we also look forward to the emergence of more innovative and practical feed additives that can contribute to the sustainable development of the feed industry.